Chemical Cannabis Tracking System Proposed In Colorado


New cannabis tracking system would place chemicals where they don’t need to be.

Colorado lawmakers are looking toward placing a “tracking agent” on legal cannabis. Even worse, the best solution to meet the needs of the scanning system is a chemical agent. If you’re alarmed by this, you are not alone. The Colorado Legislature has rejected the concept, but the only cannabis research center in the state is going ahead with the development of its seed-to-sale cannabis-tracking system (with the hopes that the bill will eventually pass). It will be voted on later this spring.

Bill SB 029

The Colorado Senate proposed bill SB 029 to enforce that all cannabis products be marked with a chemical agent that would denote these were coming from a legal source. The bill specifies, “The technology must include an agent that is applied to a marijuana plant, marijuana product, industrial hemp, or industrial hemp product and then scanned by a device.” According to the Senate, this is necessary to aid local police in monitoring all cannabis and hemp grown in the state to differentiate it from black market weed. 

Colorado, USA, legalization, cannabis, medical cannabis, recreational cannabis, cannabis tracking, vendors

In 2016, the Institute for Cannabis Research was founded at the Colorado State University-Pueblo campus. The institute is the one developing the tracking system and taxpayer money will fund it. The state will then appoint a sole vendor to sell the product. Law enforcement agencies will be able to buy the scanning technology by using grants from cannabis sales tax revenue. There has got to be some conflict of interest in here somewhere.

Proposed Bill Draws Concern

The cannabis tracking system has been rejected twice already. The Marijuana Industry of Colorado also voiced clearly that they don’t want any foreign substance added to their product.

Many industry leaders and advocates are understandably concerned. No one wants an unknown chemical added to a product meant for human consumption. The executive director of the state’s Cannabis Consumer Coalition, Larisa Bolivar, said that most cannabis consumers are not going to be happy at added chemicals in their green. Several local dispensary representatives also spoke up, calling the bill “ludicrous”.

Glenn McClellan, chief executive officer of the Grand Junction-based Source Certain International, says the subsidiary of an Australian company already has a long proven process for tracking agricultural and mineral products from source to sale. He has nothing against the idea of getting a technology that works for everyone, but says universities should open the doors for all to take part in research. They could publish criteria to state objectives and needs.

There is no Need For Such a System

Larisa Bolivar expressed her concern that very few if any, CCC members would consume or smoke cannabis with added biological or chemical agents. She believes this act would increase black market sales, rather than curb them. She goes on to say that the entire ordeal shows serious violations of individual and consumer rights – even the right to grow your own cannabis.

Bolivar fails to see the logic of the seed-to-sale tracking system in a state where adults are allowed to grow six plants on their own properties. They already can use it for personal consumption and even give it away to other adults. She asked if the bill is not rather something that could protect big-money interests while pushing out private growths, hemp farmers, and medical cannabis providers.

Colorado, USA, legalization, cannabis, medical cannabis, recreational cannabis, cannabis tracking, vendors

Support For The Cannabis Tracking System

During a news conference, Colorado Governor John Hickenlooper states that he supports the legislation because it would help the police to keep track of black market cannabis. The original cannabis law of the state allowed private growth up to six plants, but the concern is that excess product could end up on the black market. He also noted that the technology is not yet developed.

On the market, there exists an isotope tracking technology. Water used for hydrating the plants contains the isotopes and these are absorbed into the plant. The isotopes reside in the plant tissue as a tag that can be traced back to its source.

Of course, there are positive outcomes to such a system, such as tracking mold or pesticide violations. You would be able to quickly determine which producer the product came from. The downside is that the bill does not specify the agent. What if the cannabis tracking system influences the development of the plant at the seed or cellular level, thus changing genetics of carefully cultivated strains?

Lawmakers still have to vote on Senate Bill 18-029. Business, Labor, and Technology will have charge over the bill that was introduced at a Senate session in mid March, 2019.  In an age where we are trying to remove unnecessary chemicals from the environment, it seems very archaic to add them into our medicine.


Health Benefits From Cannabis Plant

Hi guys,


Long time since posting here due to new work taking most of my time.


Recently I have been diagnosed with a few deficiencies and this has got me thinking.


Sorry if this is a silly question but, does anyone one know if there any any health benefits from eating cannabis leafs?


I only ask this as all sorts of leafs are eaten in our diets and in our salads and what not.


In other words I would like to know has it been studied if there are any health giving properties from eatin cannabis leafs??


After all so many other plants are eaten so it just got me thinking if there are any healthy nutrients in the cannabis plants leafs or even other parts of the plant.


Sorry if this is a silly question guys…..

Jeremy Corbyns son tommy

Jeremy Corbyn vowed to end ‘greed is good’ capitalism in his conference speech, but his son hopes to make a fortune from cannabis culture.

Tommy Corbyn, 25, has started two companies, National Hemp Service and The Hemp Cafe, with girlfriend Chloe Kerslake-Smith, 25, to cash in on the craze for cannabis-related paraphernalia.

‘My partner and I are opening a store in North London that will sell hemp-derived products,’ 


Man arrested after cannabis factory discovered in St Albans



That’s me am away for a while be back in the future take care all :yep:


Man arrested after cannabis factory discovered in St Albans



Police carried out a drugs warrant in St Albans and discovered a suspected cannabis factory.



The warrant was carried out today in Blake Close and involved officers from Herts Police’s Scorpion Team and the St Albans Safer Neighbourhood Team.

Once inside the house officers discovered the suspected cannabis factory and seized four dogs, which are being examined to see if they are a prohibited breed.

A man in his 30s from St Albans was arrested on suspicion of cultivating cannabis, possession of a Class B drug and possession of a prohibited dog under the Dangerous Dogs Act. He remains in police custody.

St Albans Det Insp Alex Warwick said: “The supply and use of drugs can blight communities and families and will not be tolerated in St Albans.

“Those who use drugs play a part in fuelling the exploitation of vulnerable people, including children, who are often used by dealers to distribute drugs.

“If you have information about suspected drug dealing in your neighbourhood please let us know so that we can take the appropriate action.”

Anyone with information can report it online at or call the non-emergency number 101.




Pendine murder defendants say there was fight over cannabis



Pendine murder defendants say there was fight over cannabis


A father of three was stabbed to death in a fight over cannabis in Pendine, a jury has been told.

Simon Peter Clark, aged 54, was found dead on September 28 last year on the Grove caravan park.

His neighbours, Jeffrey Stephen Ward, aged 41, and Steven Baxter, 52, are said by the prosecution to have “gone on the run” and ended up at the home of Mansel Edwards and his partner Jeanine Davies in Tonypandy.

Mr Edwards said Baxter had a cut on his head and he asked him what had happened.


Baxter, he said, told him that three men had arrived at the caravan park and told Mr Clark they were there “to tax his cannabis.”

By that he understood they were going to steal it and Baxter said he and Ward had gone to Mr Clark’s assistance.

A fight had developed and they had managed to beat away the three men. It ended with Mr Clark running into his caravan and shouting that he was going to call the police.

The three men left but said they would be back.


Mr Edwards said Baxter had a black bin liner with him and said it contained “weed and cash.”

Mr Edwards said Baxter told him they had not seen Mr Clark after the fight.

“I understood they both (Baxter and Ward) grew cannabis, smoking and selling it,” added Mr Edwards.

“Simon told them he was going to call the police which is why they had to flee.”

Mr Edwards said he became worried about what had really happened. Baxter and Ward wanted to stay the night but he didn’t want them in his house and let them sleep inside a boxing club he had the keys to.


“The next morning I told them there was more to this. I was in far more than I wanted to be. I told them ‘Porth is that way, goodbye.’

“I didn’t want anything to do with it. I didn’t know at that stage that someone had been killed.”

Mr Edwards said he knew Ward well and he appeared to be subdued.

“He spent a lot of the time with his head in his hands. I thought he was frightened of the situation.

“I felt he was a lost soul, that’s how he sounded.

Jeanine Davies said she had a touring caravan on the site and was good friends with Julie Harris, Ward’s partner.

“Mansel asked what was going on. I think it was Steve who said it had come on top. I thought it was about cannabis. Three men had arrived and said they had come to tax (steal) the weed. There was an altercation.


“Steve did all the talking,” said Miss Davies.

Paul Lewis QC, the barrister leading the prosecution, told the jury it was the prosecution’s case that Baxter had invented a story about three men causing a fight to cover the fact that it was he and Ward who had attacked Mr Clark.

“Both attacked Mr Clark and Baxter stabbed him,” He said.

Baxter and Ward deny murder and the trial continues.



Police raid on village house uncovers 40 cannabis plants



Police raid on village house uncovers 40 cannabis plants


West Yorkshire Police are appealing for information after the discovery




A police raid on a house in the Holme Valley uncovered around 40 cannabis plants.

West Yorkshire Police officers carried out the raid on a property in Scotgate Road, Honley, on Tuesday.

A Force spokesman confirmed that around 40 plants had been found.

“Police received intelligence of production of cannabis at a property in Honley.

“Officers attended an address on Scotgate Road and discovered some cannabis plants.

“The plants were seized and enquires are ongoing.


“Anyone with any information is asked to contact the police via 101 quoting crime reference number 13190143057.”

The spokesman confirmed that no arrests had been made.

The discovery of the Class B follows several incidents in which cannabis plant material was discovered dumped in woodland at Honley.

In July last year dogs were poisoned after eating discarded cannabis plants near to Honley Woods. Several dogs had to be given treatment by a vet.


And in January a vet warned dog owners to be vigilant following reports of cannabis plant material being found in Honley Woods, near to Wood Bottom Road.

The plants were thought to be the remains of an illegal cannabis growing operation.






A brief history of the UK law’s relationship with medicinal cannabis



A brief history of the UK law’s relationship with medicinal cannabis


Back in the 1800s, cannabis was a ‘wonder cure’ – now, after decades of confusion and racist controversy, it may finally be a legal option once more


In early 2018, a handful of young children with severe epilepsy and their families reshaped Britain’s rigid cannabis laws by creating a PR nightmare for the Conservative government. It all started when Alfie Dingley, a six-year-old boy suffering up to 30 seizures per day, was refused a medical license for cannabis oil. Shortly afterwards, UK border authorities confiscated oil from the mother of Billy Caldwell, another epileptic child who had found no relief from standard treatments. The government’s optics on cannabis took a sharp and irreversible turn: with recreational and medical cannabis legislation well established across the US and Canada, denying suffering children treatment suddenly became an intolerably unreasonable position.

The public pressure worked. An emergency license was granted for the Caldwells in June, and for the Dingleys in July, followed by an announcement to reclassify cannabis as a schedule 2 drug in November, allowing doctors to prescribe it as a medicine. CBD oil became a legal substance to prescribe and purchase, as long as the THC content is under 0.2% (meaning there’s no chance of it getting you high). But while you might be able to grab some weed-branded CBD oil from your local health food store, prospective patients are still largely stuck without access.  And with marijuana’s confused and controversial history as a substance in the UK, it could be quite some time until the British medical community is truly 420-friendly.

Cannabis policy in the UK is largely contained to the past century, but the drug was known to the medical community for at least 60 years before that. Its earliest clinical appearance was in an 1843 medical article reporting of its effectiveness for a wide range of conditions, including cholera, tetanus, joint pain, and – most relevantly – a 40-day-old infant suffering from constant seizures. (The child had needed up to 130 drops of cannabis oil daily; the same paper reported that a willing med student guinea pig consumed only ten drops before hallucinating that he was a king, and ordering his fellow students around.) For decades, cannabis could be easily purchased, and was touted by pharmaceutical companies as a ‘wonder cure’ for menstrual pain, headaches, nausea, and other afflictions.


Advertisement, 1917


It wasn’t until 1928 that cannabis became a prohibited substance in the UK, when mounting racist fears regarding the drugs’ social influence among people of colour led politicals to criminalise it across occupied territories, and then eventually in Britain itself. Politicians in the late 19th century had become obsessed with what they claimed as madness caused by cannabis in the colonies, or as one MP put it, that the “lunatic asylums of India are filled with ganja smokers”. An official inquiry in 1894 finally proved no link between cannabis and mental health or anti-social behaviour in India, but the British government still tried to ban it four times before the turn of the century.


Similar efforts were made elsewhere, with similarly colonialist overtones: the drug was banned in Mauritius in 1840 due to its popularity “among the labouring class,” and in Jamaica in 1913 due to its “demoralising and deplorable” effect on “the natives”. It was a pretty blatant display of social control that soon leaked over into Britain itself, and the moral panic around cannabis landed it an international ban in 1928 by the League of Nations. Doctors quickly lost interest, and cannabis became viewed as a moral ill, rather than an exciting medical prospect.

It was racism, again, that fueled the government’s second significant move to prohibit cannabis as a Class B drug in the Misuse of Drugs Act 1971. Cannabis arrests had climbed dramatically during the 60s, mostly among middle class white youths, which worried politicians – to them, cannabis was bad enough when being used by people of colour and immigrants, but among wealthy young whites, it constituted a societal breakdown. The author James Mills states in his book Cannabis Nation that cannabis became symbolic of social rebellion in the UK, linking its popularity among the “counter-culture” with resistance to British social norms “at the time when the Empire was in decline and the politics of imperialism were being rejected”. Smoking weed was a way to get back at stuffy British society, and the government absolutely hated it.


Britain’s most baffling moment in its relationship with cannabis was the infamous swap from Class B to Class C (in 2004) and then back to Class B in 2009. Labour politician David Blunkett made the change as part of a harm reduction program, but also signalled that he wanted to license medical cannabis as a treatment for multiple sclerosis (MS), and expressed support for general research. That same government put it back up to a Class B in 2009, claiming it was for mental health reasons, even though its advisory board commented that evidence in this area had become “more, rather than less, confused”. Recreational weed smoking had reportedly been on the decline since the reclassification, as had hospital admissions of cannabis-related psychosis, which made the move even stranger. It seemed like the government’s main motivation, clearly alluded to by the then-Home Secretary Jacqui Smith, seemed to be to “send a message” that “the UK is not a soft touch,” regardless of how that affected medical research or actual crime and mental health rates.


A Venice Beach cannabis dispensary


Modern medical cannabis has typically had an association with ‘quack’ docs willing to dole out prescriptions over the phone for vague claims of back pain, but has been increasingly become a serious area of research, especially over the past few decades. California’s infamous and somewhat sleazy Venice Beach dispensaries are a product of the 1996 medical legislation intended to give Aids patients medical relief through cannabis, especially its nausea-eliminating and pain relief properties. The UK government even gave the green light to a cannabis research facility in 1998, an institution Theresa May personally financially benefits from – her husband’s company is its largest investor.

That same year, 1998, the House of Lords called on the government to reschedule cannabis and allow doctors to prescribe it for patients with multiple sclerosis (MS). Chronic pain was and remains a major area of medical cannabis research: chronic pain conditions are notoriously hard to treat and manage, even with opiates, and cannabis has been widely (unofficially) used by patients with conditions like fibromyalgia and MS for decades. A 2014 survey from the UK’s MS Society suggested that around one in four people with MS uses cannabis to ease their symptoms, particularly stiffness and muscle pain.



The new laws mean that some British patients can now explore these avenues legally. Sarah, a 30-year-old woman from the UK, uses CBD to manage both her fibromyalgia and her anxiety, purchasing it in an oil pen from online retailers. Prior to the change in legislation, she’d been using codeine, which dulled the pain but made her drowsy during the day and frustratingly unable to sleep at night.

“CBD really helps relieve the chronic pain associated with fibromyalgia,” Sarah* told me in an email. It’s been so useful for managing pain while reducing side effects, even her doctor has been on board.

“I told my GP and she’s been really supportive of me using it,” she said. “We both have concerns around using codeine heavily, so she was very positive about finding an alternative that works nearly as well without the drowsiness and potential for addiction.”

Not all doctors have been so open to working with patients looking to use cannabis products. Of the approximately 80,000 specialists who are theoretically permitted to prescribe the drug, few have done so. Until official recommendations are published later this year, the NHS position is to look to the British Paediatric Neurology Association (BPNA), who are not especially keen on the practice.

The BPNA advise against working with unprescribed CBD oil users like Sarah, and and do not recommend that doctors prescribe products that contain THC (such as Alfie Dingley’s Bedrolite medication). Some NHS facilities have already declared that they won’t prescribe cannabis, either due to lack of evidence, specialists, or funding. When I spoke with Professor Mike Barnes, the physician who obtained cannabis oil for the Dingley family, he called the BPNA guidelines “cautious and negative”, and confirmed what had been recently reported in the recent British Medical Journal: that not one patient has yet managed to obtain a cannabis prescription on the NHS, and only six have been doled out in the private sector.



Backlash to the effective privatisation of cannabis medicines has been widespread. Private healthcare is unattainable to most people; the first private prescription of cannabis reportedly cost £2,500 for three months of supplies. A parents’ group wrote an open letter to the BPNA in February urging them to consider the exorbitant cost of obtaining cannabis oil without a prescription, which was setting back one co-signer over £1,000 per month. They argued against the low-THC recommendations, citing stories of children struggling to transition to a CBD-only medicine, and shared the heavy toll that current anti-seizure medications have on their young children’s mental health. “Nearly every single one of the anti-epileptic drugs being prescribed for our children list anxiety and depression as a common side effect,” they implored. “Would you want to give your five-year-old something that was going to leave them with suicidal thoughts?”

Change is in motion, but it can feel painfully slow for those waiting to benefit from the new policies. On February 20, Welsh Labour MP Tonia Antoniazzi stood up during Prime Minister’s Questions to take the government to task for the lack of access to cannabis on the NHS, stating that “it’s evident that someone somewhere is blocking it”. Professor Barnes believes that while lawmakers are “very open” to the idea of medical cannabis, at least since the law has changed, “the problem in the UK is the doctors… There are some doctors in the UK who are willing and able and listening, and people will begin to prescribe soon, but it’s not going to be fast.” His own guidelines with the Medical Cannabis Commission Society will be published on March 20, and will offer what he hopes will be a balanced, alternative resource for doctors to give them confidence in prescribing cannabis products to patients in need.

For all the hesitation from doctors, Professor Barnes is optimistic about what the progress that has been made for the cannabis community in the past year means, and even believes that we might see full legalisation spread across European countries in the near future, perhaps within the next two to three years. The UK’s first medical cannabis clinic opened just this month in Cheadle, Greater Manchester, with Professor Barnes heading it up as clinical director. “We’re in a dramatically different world beginning in 2019 than last year,” he told me. “Which is good. We’ve just got a long way to go.”



Names have been changed for privacy reasons










200 cannabis plants found in terraced house operating as a ‘farm’ in Swansea city centre



200 cannabis plants found in terraced house operating as a ‘farm’ in Swansea city centre


Police were tipped off by the public




A massive cannabis factory operating on a terraced street has been dismantled by South Wales Police.

The police are currently trying to trace those responsible for the operation.

A spokeswoman for the South Wales Police said: “Acting upon intelligence from the local community, Swansea Neighbourhood Policing Team executed a warrant at and address on Rhondda Street, Mount Pleasant, at approximately 10.50am on Wednesday, March 20.

“A substantial cannabis factory covering six rooms was located, and more than 200 plants were seized.

“Enquiries are ongoing to identify and trace those involved in the operation.”






Anyone with any information which could assist the investigation should contact 101, quoting occurrence 1900098836.

Members of the public with suspicions or concerns about illegal drug activity in their community should also contact 101, or Crimestoppers anonymously on 0800 555 111.







Global Controlled Release Cannabis Pills Market 2024 Trends Forecast Analysis by Manufacturers, Regions, Type and Application



Global Controlled Release Cannabis Pills Market 2024 Trends Forecast Analysis by Manufacturers, Regions, Type and Application


Global Controlled Release Cannabis Pills Market 2024 Trends Forecast Analysis by Manufacturers, Regions, Type and Application



Controlled Release Cannabis Pills Market examine and study the market position and forecast related with production, consumption, cost structure, and historical data. Controlled Release Cannabis Pills market report provides company, products, end-user, top countries, growth trends, future prospects, segments and sub-segments.Controlled Release Cannabis Pills  Market Include Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure, and operations. The Controlled Release Cannabis Pills  Market report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

Top Manufacturers in global market are

Cannabics Pharmaceuticals, Wana Edibles, Intec Pharma


Ask & Get Sample Copy of Controlled Release Cannabis Pills Market Report @

The study report is bifurcated into the following regions on the basis of topography: North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

** Influence of the Controlled Release Cannabis Pills market report **


• Comprehensive assessment of all opportunities and risk in the Controlled Release Cannabis Pills market.

• Controlled Release Cannabis Pills market recent innovations and major events.

• Detailed study of business strategies for growth of the Controlled Release Cannabis Pills market-leading players.

• Conclusive study about the growth plot of Controlled Release Cannabis Pills market for forthcoming years.

• In-depth understanding of Controlled Release Cannabis Pills market-particular drivers, constraints and major micro markets.

• Favorable impression inside vital technological and market latest trends striking the Controlled Release Cannabis Pills market.

Do You Have Any Query or Specific Requirement? Ask to Our Industry Expert @


Product Type Segment Analysis:

* High THC Capsule
* THC/CBD Balanced Capsules
* High CBD Capsules

Applications Segment Analysis:

* Hospital Pharmacies
* Retail Pharmacies
* Drug Stores
* Online Sales


Key Reasons to Purchase:


• To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

• Assess the production processes, major issues, and solutions to mitigate the development risk.

• To understand the most affecting driving and restraining forces in the Controlled Release Cannabis Pills market and its impact in the global market.

• Learn about the market strategies that are being adopted by leading respective organizations.

• To understand the outlook and prospects for the market.




Dame Sally sees sense over cannabis – she can’t say we didn’t warn her



Dame Sally sees sense over cannabis – she can’t say we didn’t warn her


BETTER late than never, but it’s a pity that the Chief Medical Officer, Dame Sally Davies, did not see fit to warn against the perils of legalising medicinal cannabis when she had the chance to stop it.

It was on the back of her hastily compiled review of the scientific evidence and recommendations that Sajid David made good his promise last autumn to give the all-clear for clinical specialists to prescribe cannabis oil and similar products for epilepsy and multiple sclerosis.

Dame Sally’s recommendation allowed ‘cannabis-based medicinal products’ to be ‘rescheduled’ – in effect legalised – although the evidence of efficacy from her own review was extremely limited, the problems associated with the medicalisation of cannabis were well known and the testimonial evidence that so influenced the Home Secretary fell far short of the standards required for the approval of other drugs, i.e. ‘adequately powered, double blind, placebo controlled randomised clinical trials’.

Since then medical researchers have warned against unrealistic expectations for the treatment of epilepsy.


I wrote at the time that the Home Secretary, who was under huge pressure from a highly co-ordinated media campaign and cannabis legalisation lobby, was opening a Pandora’s box. Now, as commercial cannabis traders eye the UK market and ‘marijuana doctors’ promise it as helping virtually any condition from glaucoma to autism, Dame Sally has come to recognise what they have done: ‘I think we have opened a Pandora’s box and there is a belief that it works for many conditions’. Her words now, not mine, that she used to describe the effect of this policy change to MPs on the Health and Social Care Select Committee. Patients, she told them, believe (falsely) that the drug can cure multiple conditions. Furthermore, ‘despite being recently legalised for medical use’, there was currently insufficient evidence to prove the products are both effective and safe. Now she tells us.


Ironic but welcome, not least to hear her voicing her concerns about safety: ‘THC (tetrahydrocannabinol) we know has an impact on the brain and causes depression, schizophrenia, brain development problems in young and adolescents.’ It was also welcome to hear her comment, ‘If a pregnant mother was taking it I’d be very worried.’ For good reason too. Gestational cannabis has been linked with a clear continuum of birth defects in a range of longitudinal studies, as well as increased foetal death, and reflects a worldwide increase in high cannabis-using areas. It’s high time we had full public health information about quite how dangerous (in so many ways) this addictive and therefore difficult to treat drug can be.

At least Dame Sally is now listening. Perhaps she might now encourage the Home Secretary to review his ill-considered decision.



Your message has been successfully sent.
Oops! Something went wrong.

Get in touch

If you wish to enquire about anything, or just say hi, please fill in the form opposite, or email us on:

Copyright 2020